the regulation of biosimilars
Published 7 years ago • 93 plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
3:09
biosimilars vs. generic drugs
-
2:40
understanding biosimilars
-
3:30
are biosimilars similar enough?
-
1:18
can biosimilars ensure access to drugs for everyone?
-
2:43
why do we need biosimilars?
-
1:35:15
monday, june 20, 2016: biosimilars in the united states: next steps
-
3:00
biosimilars: complex copycat drugs
-
4:20
the biosimilar development process
-
1:42
advantages of using biosimilars
-
5:28
the potential impact of biosimilars in hematology
-
4:12
the basics of biosimilars
-
38:15
biosimilars and biologics
-
1:52
biosimilars - the question of trials and approval
-
2:34
the impact of ethnicity on biomarker-based staging in al amyloidosis
-
2:17
what are biosimilars?
-
1:53
what are biosimilars?
-
1:36
a look at the expansion of a biosimilar’s fda label with sue naeyaert
-
1:48
dr. markman on the concept of biosimilars in oncology
-
6:02
the evolution of biotechnology – the arrival of biosimilars
-
21:21
beyond reference biologics: biosimilars on the horizon
-
3:18
what is a biosimilar, exactly?
-
7:22
an overview of biosimilarity